Squarepoint’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,391
Closed -$73K 3707
2022
Q3
$73K Sell
18,391
-171,158
-90% -$1.05M ﹤0.01% 2830
2022
Q2
$1.05M Buy
189,549
+160,358
+549% +$1.31M 0.01% 1573
2022
Q1
$429K Sell
29,191
-44,022
-60% -$589K ﹤0.01% 2095
2021
Q4
$1.16M Buy
+73,213
New +$1.76M ﹤0.01% 1604
2021
Q3
Sell
-31,200
Closed -$1.3M 3564
2021
Q2
$1.3M Buy
31,200
+20,506
+192% +$842K ﹤0.01% 1449
2021
Q1
$543K Buy
+10,694
New +$559K ﹤0.01% 1952

Other funds holding DMTK

Squarepoint's DMTK Position: Q4 2022 in Review

Squarepoint sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 18,391 shares — an estimated $73K sold.

Squarepoint first reported a position in DMTK in Q1 2021 and held it in 6 quarters. The position peaked at $1.3M in Q2 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • Squarepoint reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Squarepoint sold 18,391 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $73K.
  • Squarepoint first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Squarepoint's DermTech, Inc. Common Stock position peaked at $1.3M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.